We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Lab-on-a-Chip Platform Designed for Detection of Pathogens

By LabMedica International staff writers
Posted on 04 Apr 2017
A team of German bioengineers has developed an integrated and automated lab-on-a-chip platform for sample preparation and nucleic acid-based detection of pathogens in various liquid media.

Since DNA-based detection of the pathogens in liquid samples demands many complex steps, various pieces of equipment, and experienced personnel, investigators at Fraunhofer Institute for Cell Therapy & Immunology developed an innovative prototype lab-on-a-chip platform capable of automating the process in a single instrument.

The system includes a microfluidic cartridge (lab-on-a-chip) and an external tabletop instrument. More...
The simple linear design of the cartridge is based on stationary microfluidics, which does not require valves or actuators. This concept is realized via the implementation of functionalized magnetic beads for pathogen isolation and DNA extraction.

The external instrument manages bead transportation and temperature control in the reaction chambers in a user-independent mode, and the user-friendly software allows adjusting these processes as required. The detection of the amplified product is performed with a LED-based optical unit that provides the readout of the fluorescent signal.

The investigators demonstrated proof-of-concept by detecting E. coli and Salmonella as two model pathogens in spiked liquid samples via loop-mediated isothermal amplification (LAMP) and PCR. They worked with one-milliliter samples but stated that this volume could be easily scaled up.

"We were motivated by the existing need for making the molecular analysis of complex samples much simpler for the users," said first author Dr. Natalia Sandetskaya, a researcher in the nanotechnology unit at Fraunhofer Institute for Cell Therapy & Immunology. "Our particular applied interest is the detection of the pathogens in blood; for instance in sepsis, when only a few microorganisms must be rapidly found in a large volume of blood. Although our current prototype of the platform will need further development for this application, we have already demonstrated a high level of integration of very diverse processes without making the system overly complex."

Details of the device were published in the March 22, 2017, online edition of the journal Future Science OA.


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.